CardioFocus Announces European CE Mark Approval Of The Next-Generation HeartLight Excalibur Balloon Designed For The Treatment Of Atrial Fibrillation Post author:Sam Post published:September 26, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like What Makes Biogen and Bristol-Myers Squibb Such Attractive Takeover Targets June 26, 2017 Novan Lays Off 20% of Workforce, Switches Up C-Suite June 5, 2017 Biocryst Announces Full Exercise Of Underwriters??? Option To Purchase Additional Shares And Completion Of Public Offering Of Common Stock September 17, 2017
Biocryst Announces Full Exercise Of Underwriters??? Option To Purchase Additional Shares And Completion Of Public Offering Of Common Stock September 17, 2017